Antiviral therapy is the treatment of HBV effects

Anti-virus treatment timing is important Chronic hepatitis B antiviral therapy is a professional and highly technical work, the need for specific experience specialists to determine whether to implement the conditions, not based on the wishes of patients or request for a decision. These technical issues, including the timing of the treatment grasp, drug choice, the length of treatment, and withdrawal after stopping standard monitoring, relapse after treatment. To grasp the opportunity for example, the normal immune tolerance aminotransferase patients, the virus carriers often said, the implementation of anti-viral therapy like "beyond the reach", will not be effective, it can not be hurried, only close observation, patience. Otherwise it will be "Destructive Enthusiasm." The right has entered the immune clearance phase of patients with abnormal liver function should be implemented as soon as possible anti-viral treatment. Especially for an early cirrhosis or liver cirrhosis patients tend to be more adversely affected by aircraft, as soon as possible "to remedy the situation." Some people believe that the main hepatitis is abnormal liver function, elevated transaminases, as long as Baogan, JiangMei on the trip. Actually not, if an effective antiviral therapy is the prerequisite for a 1988 is the liver enzyme also difficult to maintain normal, or slowing the progression of progress, improve the prognosis. Anti - hepatitis B virus treatment has become a consensus Many patients, chronic hepatitis B without justified, applied. In fact, this is one-sided and inaccurate. Currently, antiviral treatment of chronic hepatitis B is the fundamental method of treatment as a consensus recognized effective antiviral drugs are nucleoside analogues and interferon, hepatitis B virus to these drugs significantly inhibited. To lamivudine for example, patients receiving treatment in 2-4 weeks time, HBV viral load can be decreased rapidly, reaching 1000-10000 times, accompanied by improved liver function. From inhibit the virus and improve liver function point of view, these drugs is not justified, anti-virus treatment is the treatment effects. Many of the existing research results suggest that sustained high levels of hepatitis B virus replication in the development of cirrhosis and liver cancer risk factors and effective antiviral treatment can reduce the level of viremia, or shorten the time can reduce the occurrence of liver cirrhosis and liver cancer rates. Therefore, to effectively prevent the disease progress, improve the prognosis, the treatment of life-prolonging treatment of the same effects can count.